Loading clinical trials...
Loading clinical trials...
A Phase II Randomized and Controlled Investigation of Six Weeks of Oral Valganciclovir Therapy in Infants and Children With Congenital Cytomegalovirus Infection and Hearing Loss
Conditions
Interventions
Placebo
Valganciclovir
Locations
18
United States
Children's of Alabama Child Health Research Unit (CHRU)
Birmingham, Alabama, United States
Children's National Medical Center - Sheikh Zayed Campus - Infectious Disease
Washington D.C., District of Columbia, United States
Washington University School of Medicine in St. Louis - Center for Clinical Studies
St Louis, Missouri, United States
Steven and Alexandra Cohen Childrens Medical Center of New York - New Hyde Park - Infectious Disease
Manhasset, New York, United States
University of Rochester Medical Center
Rochester, New York, United States
Carolinas Medical Center - Pediatrics - Infectious Diseases
Charlotte, North Carolina, United States
Start Date
February 24, 2015
Primary Completion Date
December 24, 2019
Completion Date
December 24, 2019
Last Updated
October 16, 2024
NCT07294547
NCT06926894
NCT05626530
NCT02007356
NCT05701228
NCT05089630
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions